These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 32419646)

  • 1. Design of multi-epitope vaccine candidate against SARS-CoV-2: a
    Abraham Peele K; Srihansa T; Krupanidhi S; Ayyagari VS; Venkateswarulu TC
    J Biomol Struct Dyn; 2021 Jul; 39(10):3793-3801. PubMed ID: 32419646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
    Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
    Singh J; Malik D; Raina A
    Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.
    Jyotisha ; Singh S; Qureshi IA
    J Biomol Struct Dyn; 2022 Apr; 40(7):2917-2933. PubMed ID: 33164664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
    Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM
    PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
    Yang Z; Bogdan P; Nazarian S
    Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Devi A; Chaitanya NSN
    J Biomol Struct Dyn; 2021 Nov; 39(18):6903-6917. PubMed ID: 32772892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    Almofti YA; Abd-Elrahman KA; Eltilib EEM
    BMC Immunol; 2021 Mar; 22(1):22. PubMed ID: 33765919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoinformatics prediction of overlapping CD8
    Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
    Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A candidate multi-epitope vaccine against SARS-CoV-2.
    Kar T; Narsaria U; Basak S; Deb D; Castiglione F; Mueller DM; Srivastava AP
    Sci Rep; 2020 Jul; 10(1):10895. PubMed ID: 32616763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple epitope-based vaccine prediction against SARS-CoV-2 spike glycoprotein.
    Sirohi PR; Gupta J; Somvanshi P; Prajapati VK; Grover A
    J Biomol Struct Dyn; 2022 May; 40(8):3347-3358. PubMed ID: 33246394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
    Marchan J
    J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Mitra D; Pandey J; Jain A; Swaroop S
    J Biomol Struct Dyn; 2022 Jul; 40(11):5189-5202. PubMed ID: 33403946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes.
    Jain N; Shankar U; Majee P; Kumar A
    Infect Genet Evol; 2021 Jan; 87():104648. PubMed ID: 33264668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering receptor-binding domain and heptad repeat domains towards the development of multi-epitopes oral vaccines against SARS-CoV-2 variants.
    Arshad NF; Nordin FJ; Foong LC; In LLA; Teo MYM
    PLoS One; 2024; 19(8):e0306111. PubMed ID: 39146295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An
    Dar HA; Waheed Y; Najmi MH; Ismail S; Hetta HF; Ali A; Muhammad K
    J Immunol Res; 2020; 2020():8893483. PubMed ID: 33274246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling mRNA-based vaccine YFV.E1988 against yellow fever virus E-protein using immuno-informatics and reverse vaccinology approach.
    Khan NT; Zinnia MA; Islam ABMMK
    J Biomol Struct Dyn; 2023 Mar; 41(5):1617-1638. PubMed ID: 34994279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
    Akhtar N; Joshi A; Singh B; Kaushik V
    Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
    Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
    Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.